Since no drug has been approved for PTSD treatment, we want to know if this one will help patients. Post-traumatic stress disorder is a condition resulting from a traumatic event that involved the threat of real injury or death.
Patients commonly express feelings of intense fear, helplessness, or horror.
Inc. More than 600 PTSD patients in the United States will participate in the study. Those eligible must exhibit signs of post-traumatic stress disorder, be aged 18 or older, in good health and not currently taking any psychiatric medication. Participants will receive a physical examination, blood chemistry tests and an electrocardiogram. Patients will take either the medication or a placebo daily and visit the medical center psychiatric clinic weekly for four weeks. During the final 10 weeks of the study, patients will return to the clinic every two weeks.